Tuesday, August 4, 2026

Revolutionary DiSPo Model: How KAIST’s AI Boosts Robot Precision by 81% with Minimal Data

KAIST's DiSPo model enables robots to learn precise movements with minimal data, enhancing applications in manufacturing and healthcare.

North Korea Honors Russian Troops: What This Means for National Identity and Economic Independence

Kim Jong Un oversees sculpture projects honoring Russian troops, promoting self-reliance and national identity in North Korea's economy.

How AI Read CXR is Transforming Chest X-Ray Analysis: A Deep Dive into the First AI Medical Device Approved in Korea

South Korea's first generative AI medical device, AI Read X-ray, gains approval for interpreting X-rays with radiologist-level accuracy.

Tag: BAL0891

Sillajen Presents Early BAL0891 Clinical Findings at ASCO 2026, Highlighting Safety and Early Anti-Cancer Activity

ShillaGen presented initial clinical research results of its cancer drug BAL0891 at ASCO, showcasing promising developments.

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Breakthrough Cancer Drug BAL0891: Key Findings to be Revealed at AACR 2026

SillaJen's cancer drug BAL0891 will be presented at the AACR 2026 conference, highlighting its effects on gastric and breast cancer models.

Top News

- Our Sponsors Ad -

Follow us